Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of potential drug-drug interaction (pDDI) frequency studies in the intensive care unit (ICU).|
|Full bibliographic reference||Bakker T, Dongelmans DA, Nabovati E, Eslami S, de Keizer NF, Abu-Hanna A, Klopotowska JE. Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations. J Clin Pharmacol. 2021.|
(full-text if available)
|Read the full-text of this reporting guideline.|
|Study design||Observational studies|
|Applies to the whole report or to individual sections of the report?||Procedure/Method, Study characteristics (participants etc.)|
|Record last updated on||March 10, 2022|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.